Literature DB >> 16118414

Construction of human naïve Fab library and characterization of anti-met Fab fragment generated from the library.

Yongjun Jiao1, Ping Zhao, Jin Zhu, Tessa Grabinski, Zhengqing Feng, Xiaohong Guan, R Scot Skinner, Milton D Gross, Rick V Hay, Hiroshi Tachibana, Brian Cao.   

Abstract

Inappropriate expression of the receptor tyrosine kinase Met and its ligand hepatocyte growth factor (HGF)/scatter factor (SF) is usually associated with an aggressive solid tumor phenotype (angiogenesis, invasiveness, and metastasis) and poor clinical prognosis. We report here the design and construction of a large, human naïve antigen-binding fragment (Fab) phage-display library with a diversity of 2.0 x 109, which allows rapid isolation of antigen-specific human antibody fragments. A Fab fragment specifically against Met (designated hFab-Met-1) was successively selected from this library by using biopanning on Met-transfected cell line S114. The specificity of hFab-Met-1 was characterized by immunoprecipitation, Western blotting, and flow cytometry. The results demonstrate that hFab-Met-1 reacts with the extracellular domain of Met in its native conformation. Moreover, functional analysis by Madine-Darby canine kidney cell scattering and urokinase-type plasminogen activator assays demonstrated that hFab-Met-1 is not an agonist to HGF/Met signaling compared with a murine intact monoclonal antibody (MAb) Met5. To confirm that hFab-Met-1 interacts with Met-expressing tumors in vivo, I-125-labeled hFab-Met-1 was nuclear-imaged in a mouse xenograft of Met- and HGF/SF-expressing human leiomyosarcoma. Total body scintigrams were obtained between 1 and 48 h postinjection (PI). Tumor-associated activity was imaged as early as 1 h PI, and remained visible in some animals as late as 24 h PI. As expected, activity was highest in the kidneys in early images, whereas thyroid activity became predominant in later images. In conclusion, hFab-Met-1 interacts with Met both in vitro and in vivo, and is a promising candidate for clinical diagnosis and therapeutics.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16118414     DOI: 10.1385/mb:31:1:041

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.695


  48 in total

Review 1.  Improving the efficacy of antibody-based cancer therapies.

Authors:  P Carter
Journal:  Nat Rev Cancer       Date:  2001-11       Impact factor: 60.716

2.  Improved gene transfer selectivity to hepatocarcinoma cells by retrovirus vector displaying single-chain variable fragment antibody against c-Met.

Authors:  Tuan Huy Nguyen; Nathalie Loux; Ibrahim Dagher; Corinne Vons; Ken Carey; Pascale Briand; Michelle Hadchouel; Dominique Franco; Jacqueline Jouanneau; Ralph Schwall; Anne Weber
Journal:  Cancer Gene Ther       Date:  2003-11       Impact factor: 5.987

Review 3.  Antibodies from phage antibody libraries.

Authors:  Andrew R M Bradbury; James D Marks
Journal:  J Immunol Methods       Date:  2004-07       Impact factor: 2.303

4.  Sustained survival of human hepatocytes in mice: A model for in vivo infection with human hepatitis B and hepatitis delta viruses.

Authors:  K Ohashi; P L Marion; H Nakai; L Meuse; J M Cullen; B B Bordier; R Schwall; H B Greenberg; J S Glenn; M A Kay
Journal:  Nat Med       Date:  2000-03       Impact factor: 53.440

5.  High level production of soluble single chain antibodies in small-scale Escherichia coli cultures.

Authors:  S M Kipriyanov; G Moldenhauer; M Little
Journal:  J Immunol Methods       Date:  1997-01-15       Impact factor: 2.303

Review 6.  Phage display of combinatorial antibody libraries.

Authors:  C Rader; C F Barbas
Journal:  Curr Opin Biotechnol       Date:  1997-08       Impact factor: 9.740

Review 7.  New paradigms for the treatment of cancer: the role of anti-angiogenesis agents.

Authors:  J M Cherrington; L M Strawn; L K Shawver
Journal:  Adv Cancer Res       Date:  2000       Impact factor: 6.242

8.  Penetration and binding of radiolabeled anti-carcinoembryonic antigen monoclonal antibodies and their antigen binding fragments in human colon multicellular tumor spheroids.

Authors:  R Sutherland; F Buchegger; M Schreyer; A Vacca; J P Mach
Journal:  Cancer Res       Date:  1987-03-15       Impact factor: 12.701

9.  Human antibody fragments specific for human blood group antigens from a phage display library.

Authors:  J D Marks; W H Ouwehand; J M Bye; R Finnern; B D Gorick; D Voak; S J Thorpe; N C Hughes-Jones; G Winter
Journal:  Biotechnology (N Y)       Date:  1993-10

10.  Reduced c-Met expression by an adenovirus expressing a c-Met ribozyme inhibits tumorigenic growth and lymph node metastases of PC3-LN4 prostate tumor cells in an orthotopic nude mouse model.

Authors:  Sun Jin Kim; Marjorie Johnson; Kristen Koterba; Matthew H Herynk; Hisanori Uehara; Gary E Gallick
Journal:  Clin Cancer Res       Date:  2003-11-01       Impact factor: 12.531

View more
  12 in total

1.  A human anti-c-Met Fab fragment conjugated with doxorubicin as targeted chemotherapy for hepatocellular carcinoma.

Authors:  Ximin Chen; Guipeng Ding; Qihe Gao; Jian Sun; Qianqian Zhang; Lijian Du; Zhenning Qiu; Changjun Wang; Feng Zheng; Bowang Sun; Jian Ni; Zhenqing Feng; Jin Zhu
Journal:  PLoS One       Date:  2013-05-13       Impact factor: 3.240

2.  Human antibody neutralizes severe Fever with thrombocytopenia syndrome virus, an emerging hemorrhagic Fever virus.

Authors:  Xiling Guo; Li Zhang; Wenshuai Zhang; Ying Chi; Xiaoyan Zeng; Xian Li; Xian Qi; Qiu Jin; Xiao Zhang; Mingming Huang; Hua Wang; Yin Chen; Changjun Bao; Jianli Hu; Shuyi Liang; Lin Bao; Tao Wu; Minghao Zhou; Yongjun Jiao
Journal:  Clin Vaccine Immunol       Date:  2013-07-17

3.  Targeting c-Met on gastric cancer cells through a fully human fab antibody isolated from a large naive phage antibody library.

Authors:  Bahareh Zarei; Zahra Javidan; Elnaz Fatemi; Fatemeh Rahimi Jamnani; Shohreh Khatami; Vahid Khalaj
Journal:  Daru       Date:  2020-03-19       Impact factor: 3.117

4.  A Human Anti-Toll Like Receptor 4 Fab Fragment Inhibits Lipopolysaccharide-Induced Pro-Inflammatory Cytokines Production in Macrophages.

Authors:  Maorong Wang; Wenkai Zheng; Xuhui Zhu; Jing Xu; Binggang Cai; Yiqing Zhang; Feng Zheng; Linfu Zhou; Zhiguo Yang; Xin Zhang; Changjun Wang; Shinan Nie; Jin Zhu
Journal:  PLoS One       Date:  2016-01-19       Impact factor: 3.240

5.  The Fab Fragment of a Human Anti-Siglec-9 Monoclonal Antibody Suppresses LPS-Induced Inflammatory Responses in Human Macrophages.

Authors:  Sasa Chu; Xuhui Zhu; Na You; Wei Zhang; Feng Zheng; Binggang Cai; Tingting Zhou; Yiwen Wang; Qiannan Sun; Zhiguo Yang; Xin Zhang; Changjun Wang; Shinan Nie; Jin Zhu; Maorong Wang
Journal:  Front Immunol       Date:  2016-12-26       Impact factor: 7.561

Review 6.  Analysis of progress and challenges for various patterns of c-MET-targeted molecular imaging: a systematic review.

Authors:  Zhaoguo Han; Yongyi Wu; Kai Wang; Yadi Xiao; Zhen Cheng; Xilin Sun; Baozhong Shen
Journal:  EJNMMI Res       Date:  2017-05-08       Impact factor: 3.138

7.  High-Affinity Human Anti-c-Met IgG Conjugated to Oxaliplatin as Targeted Chemotherapy for Hepatocellular Carcinoma.

Authors:  Yilan Ma; Mingjiong Zhang; Jiayan Wang; Xiaochen Huang; Xingwang Kuai; Xiaojuan Zhu; Yuan Chen; Lizhou Jia; Zhenqing Feng; Qi Tang; Zheng Liu
Journal:  Front Oncol       Date:  2019-08-02       Impact factor: 6.244

8.  A novel multipurpose monoclonal antibody for evaluating human c-Met expression in preclinical and clinical settings.

Authors:  Beatrice S Knudsen; Ping Zhao; James Resau; Sandra Cottingham; Ermanno Gherardi; Eric Xu; Bree Berghuis; Jennifer Daugherty; Tessa Grabinski; Jose Toro; Troy Giambernardi; R Scot Skinner; Milton Gross; Eric Hudson; Eric Kort; Ernst Lengyel; Aviva Ventura; Richard A West; Qian Xie; Rick Hay; George Vande Woude; Brian Cao
Journal:  Appl Immunohistochem Mol Morphol       Date:  2009-01

9.  Generation and characterization of a novel recombinant antibody against LMP1-TES1 of Epstein-Barr virus isolated by phage display.

Authors:  Dawei Zhang; Yuan Mao; Qing Cao; Lin Xiong; Juan Wen; Renjie Chen; Jin Zhu
Journal:  Viruses       Date:  2013-04-22       Impact factor: 5.048

10.  Optical Imaging of Mesenchymal Epithelial Transition Factor (MET) for Enhanced Detection and Characterization of Primary and Metastatic Hepatic Tumors.

Authors:  Shadi A Esfahani; Pedram Heidari; Sun A Kim; Shuji Ogino; Umar Mahmood
Journal:  Theranostics       Date:  2016-09-09       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.